The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone

Pharmacopsychiatry. 2012 Nov;45(7):292-6. doi: 10.1055/s-0032-1309004. Epub 2012 May 21.

Abstract

Akathisia as well as younger age, early illness onset and discharge are important risk factors for suicidality in patients with first-episode schizophrenia. The aim of the present study was to analyze on a single case basis the relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician- and patient-rated akathisia. A small subsample of patients demonstrated a positive relationship between suicidality and akathisia scores within the titration period of the study medication.

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Akathisia, Drug-Induced / psychology*
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Anxiety / chemically induced
  • Female
  • Haloperidol / adverse effects*
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales / statistics & numerical data
  • Risk Factors
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology*
  • Suicidal Ideation*

Substances

  • Antipsychotic Agents
  • Haloperidol
  • Risperidone